Síndrome pós-Covid-19: breve revisão sistemática / Long-Covid: brief systematic review
DOI:
https://doi.org/10.34119/bjhrv5n2-150Keywords:
covid-19, infecção por sars-cov-2, síndrome pós-covid.Abstract
A COVID-19 é uma infecção respiratória aguda causada pelo Coronavírus-2 da Síndrome Respiratória Aguda Grave (SARS-COV-2). Sua transmissibilidade, através do contato direto ou com gotículas de pessoas infectadas, permitiu-o se alastrar da China para o mundo, resultando em uma pandemia global com milhões de mortes. Dentre as vítimas infectadas que sobreviveram à patologia, há indivíduos que continuam manifestando sintomas remanescentes após a fase aguda, sendo tais sintomas concernentes à Síndrome Pós-COVID. Este estudo objetiva averiguar o conteúdo bibliográfico disponível acerca das manifestações da Síndrome pós-COVID. Trata-se de uma revisão sistemática, com buscas nas bases de dados PUBMED, SciELO e LILACS, utilizando os operadores booleanos: (LONG-COVID) OR (CHRONIC COVID SYNDROME) OR (LONG-HAUL COVID) OR (POST-ACUTE COVID-19 SYNDROME). Excluiu-se artigos que não se enquadravam na temática proposta, que estavam indisponíveis, que eram duplicatas ou que não fossem em língua inglesa, portuguesa ou espanhola. Foram encontrados 579 artigos e, desses, 20 estudos foram incluídos. Dentre os sintomas manifestados na Síndrome Pós-COVID, constata-se que fadiga, mialgia, dispneia, cefaleia, anosmia, ageusia e artralgia são os sintomas mais relatados pelos estudos. As inflamações no sistema nervoso acarretam sintomas como déficit de atenção, “brain fog”, desordem de memória e distúrbios do sono. Disfunções psicológicas estão presentes, tais quais depressão, anedonia, ansiedade, estresse pós-traumático, letargia e humor triste. Esses sintomas prejudicam a qualidade de vida do indivíduo ao dificultar a realização de atividades habituais. Enfatiza-se a necessidade de acompanhamento multiprofissional nos pacientes convalescentes da COVID-19, para mitigar suas complicações e sequelas.
References
Islam M, Islam US, Mosaddek ASM, Potenza MN, Pardhan S. Treatment, persistent symptoms, and depression in people infected with COVID-19 in Bangladesh. Int J Environ Res Public Health. 2021;18(4):1453.
Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol [Internet]. 2020 Apr 1;92(4):418–23. Available from: https://doi.org/10.1002/jmv.25681
Kempuraj D, Selvakumar GP, Ahmed ME, Raikwar SP, Thangavel R, Khan A, et al. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation. Neurosci [Internet]. 2020 Jul 18;26(5–6):402–14. Available from: https://doi.org/10.1177/1073858420941476
Ministério da Saúde. Guia de Vigilância Epidemiológica — Emergência de Saúde Pública de Importância Nacional pela Doença pelo Coronavírus 2019. Brasília: Ministério da Saúde; 2020. 37 p.
Carfì A, Bernabei R, Landi F, Group for the GAC-19 P-ACS. Persistent Symptoms in Patients After Acute COVID-19. JAMA [Internet]. 2020 Aug 11;324(6):603–5. Available from: https://doi.org/10.1001/jama.2020.12603
Fraser E. Long term respiratory complications of covid-19. BMJ [Internet]. 2020 Aug 3;370:m3001. Available from: http://www.bmj.com/content/370/bmj.m3001.abstract
Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post ‑ COVID ‑ 19 Symptom Burden : What is Long ‑ COVID and How Should We Manage It ? 2021;(0123456789).
Moreno-Pérez O, Merino E, Leon-Ramirez J-M, Andres M, Ramos JM, Arenas-Jiménez J, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect. 2021;82(3):378–83.
Gaber TAK, Ashish A, Unsworth A. Persistent post-covid symptoms in healthcare workers. 2021;932(June 2020):2–4.
Stormorken E, Jason LA, Kirkevold M. Factors impacting the illness trajectory of post-infectious fatigue syndrome: a qualitative study of adults’ experiences. BMC Public Health. 2017;17(1):1–18.
Makaronidis J, Firman C, Magee CG, Mok J, Balogun N, Lechner M, et al. Distorted chemosensory perception and female sex associate with persistent smell and / or taste loss in people with SARS-CoV- 2 antibodies : a community based cohort study investigating clinical course and resolution of acute smell and / or taste loss in people with and without SARS-CoV-2 antibodies in London, UK. 2021;1–11.
Petersen MS, Kristiansen MF, Hanusson KD, Danielsen ME, Steig B, Gaini S, et al. Long COVID in the Faroe Islands : A Longitudinal Study Among Nonhospitalized Patients. 2020;(Xx):1–6.
Jacobson KB, Rao M, Bonilla H, Subramanian A, Hack I, Madrigal M, et al. Patients With Uncomplicated Coronavirus Disease 2019 (COVID-19) Have Long-Term Persistent Symptoms and Functional Impairment Similar to Patients with Severe COVID-19: A Cautionary Tale During a Global Pandemic. Clin Infect Dis. 2021;
Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al. ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76(4):396–8.
Osikomaiya B, Erinoso O, Wright KO, Odusola AO, Thomas B, Adeyemi O, et al. ‘ Long COVID ’ : persistent COVID-19 symptoms in survivors managed in Lagos State , Nigeria. BMC Infect Dis. 2021;304(21):1–7.
Iqbal A, Iqbal K, Ali SA, Azim D, Farid E, Baig MD, et al. The COVID-19 Sequelae : A Cross-Sectional Evaluation of Post-recovery Symptoms and the Need for Rehabilitation of COVID-19 Survivors. 2021;2(2).
Humphreys H, Kilby L, Kudiersky N, Copeland R. Long COVID and the role of physical activity: a qualitative study. BMJ Open. 2021;11(3):e047632.
dos Santos IAM, Accorsi DX, Accorsi JX, Bohac S, Chin CM. COVID-19 e Saúde Mental. ULAKES J Med. 2020;1.
Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;
Basta M, Chrousos GP, Vela-Bueno A, Vgontzas AN. Chronic insomnia and the stress system. Sleep Med Clin. 2007;2(2):279–91.
Bellan M, Soddu D, Balbo PE, Baricich A, Zeppegno P, Avanzi GC, et al. Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge. JAMA Netw Open [Internet]. 2021 Jan 27;4(1):e2036142–e2036142. Available from: https://doi.org/10.1001/jamanetworkopen.2020.36142
Shalev A, Liberzon I, Marmar C. Post-traumatic stress disorder. N Engl J Med. 2017;376(25):2459–69.
Simani L, Ramezani M, Darazam IA, Sagharichi M, Aalipour MA, Ghorbani F, et al. Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19. J Neurovirol [Internet]. 2021;27(1):154–9. Available from: https://doi.org/10.1007/s13365-021-00949-1
Rasa S, Nora-Krukle Z, Henning N, Eliassen E, Shikova E, Harrer T, et al. Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med [Internet]. 2018;16(1):268. Available from: https://doi.org/10.1186/s12967-018-1644-y
Guedj E, Million M, Dudouet P, Bregeon F, Cammilleri S, Raoult D. F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection : substrate for persistent / delayed disorders ? 2021;592–5.
Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, et al. Multiorgan impairment in low- risk individuals with post- syndrome : a prospective , community- based study. 2021;2–7.
Sayed S El, Shokry D, Mohamed S. Post-COVID-19 fatigue and anhedonia : A cross-sectional study and their correlation to post-recovery period. 2021;(August 2020):50–5.
Shah S, Danda D, Kavadichanda C, Das S, Adarsh MB, Negi VS. Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment. Rheumatol Int. 2020;40(10):1539–54.
Anzai A, Wang EHC, Lee EY, Aoki V, Christiano AM. Pathomechanisms of immune-mediated alopecia. Int Immunol. 2019;31(7):439–47.
Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature [Internet]. 2021; Available from: https://doi.org/10.1038/s41586-021-03553-9.
